Published in Lab Law Weekly, June 23rd, 2006
According to a report from Italy, "Eotaxin (CCL 11) is an eosinophil-specific chemo-attractant which has been found to be highly expressed at sites of vascular pathology. In the present study, we aimed to evaluate the association of plasma eotaxin levels with the presence and extent of angiographic coronary artery disease (CAD)."
University of Pavia researchers E. Emanuele and colleagues explained, "Three hundred and fifty six consecutive patients attending for elective coronary angiography were investigated. Compared with 111 patients without...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.